AutoGenomics Company
AutoGenomics, Inc., a privately held company based in Vista, CA has developed one of the first automated microarray based multiplexing molecular diagnostic platforms that can be used to assess disease signatures with novel genetic biomarkers in the areas of women's health, cancer and personalized medicine. With discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed, leading to a new era of personalized medicine.
Total Funding:
$67 M
Headquarters:
Vista, California, United States
Funding Status:
Venture - Series Unknown
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Technology:
Biomarkers of General Women's Health Biomarkers, Biomarkers of Female Reproductive Health
Last Funding Date:
2013-01-11
Founded Date:
2013
Industry:
Women Cancer Treatment